When developing anticancer therapeutics, most researchers aim to kill cancerous cells. However, Hiroki Yokota’s approach is to control their growth by knowing how to grow them. Yokota, a professor of biomedical engineering at the School of Engineering and Technology at IUPUI, an adjunct professor of anatomy, cell biology and physiology at the IU School of… Read more »
Tag: IU School of Medicine
IU researcher’s drug to slow diabetic retinopathy successfully completes Phase 2 trial
Mark R. Kelley, the Betty and Earl Herr professor of pediatric oncology research at the Indiana University School of Medicine and associate director of basic science at the IU Melvin and Bren Simon Comprehensive Cancer Center, is celebrating the positive Phase 2 trial results of a first-of-its-kind drug he developed to slow the progression of… Read more »
IU researchers create gene therapeutic for the treatment of inherited genetic diseases
Despite significant improvements in gene therapy in recent years, there are still major drawbacks such as the lack of development of more accessible gene therapies for those with inherited genetic diseases due to a missing or defective gene or gene product. For those individuals, there are limited individualized therapies geared toward their genetic makeup. Weidong… Read more »